Clinical Pharmacokinetics of Fluvoxamine

@article{Perucca1994ClinicalPO,
  title={Clinical Pharmacokinetics of Fluvoxamine},
  author={Emilio Perucca and Giuliana Gatti and Edoardo Spina},
  journal={Clinical Pharmacokinetics},
  year={1994},
  volume={27},
  pages={175-190}
}
  • Emilio Perucca, Giuliana Gatti, Edoardo Spina
  • Published 1994
  • Medicine
  • Clinical Pharmacokinetics
  • SummaryFluvoxamine is a selective inhibitor of serotonin reuptake that is widely used in the management of depression.Following oral administration, the drug is absorbed efficiently from the gastrointestinal tract. Peak plasma concentrations are usually observed within 2 to 8 hours postdose for capsules and film-coated tablets and within 4 to 12 hours for enteric-coated tablets. Despite complete absorption, oral bioavailability may be incomplete probably because of first-pass metabolism… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 39 CITATIONS, ESTIMATED 65% COVERAGE

    Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Management of obsessive-compulsive disorder with fluvoxamine extended release

    VIEW 5 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Interaction Study Between Enoxacin and Fluvoxamine

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Fluvoxamine inhibits the CYP2C19-catalysed metabolism of proguanil in vitro

    VIEW 1 EXCERPT
    CITES METHODS

    Pharmacokinetics of serotonergic drugs: focus on OCD

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    1998
    2020

    CITATION STATISTICS

    • 8 Highly Influenced Citations